Pulmonary Hypertension: Difference between revisions

From Echopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 9: Line 9:
!Subcategories
!Subcategories
|-
|-
!Pulmonary Arterial Hypertension(PAH)
|Pulmonary Arterial Hypertension(PAH)
|
|
*Idiopathic PAH(unknown cause)
*Idiopathic PAH(unknown cause)
Line 16: Line 16:
*PAH with significant venous and / or capillary involvement
*PAH with significant venous and / or capillary involvement
*Persistent pulmonary hypertension of newborn
*Persistent pulmonary hypertension of newborn
 
|-
Pulmonary hypertension with left heart disease
|Pulmonary hypertension with left heart disease
 
|
*In disorders of left atrium and ventricle
*In disorders of left atrium and ventricle
of the heart
of the heart
*With Valvular
*With Valvular
 
|-
Pulmonary hypertension in pulmonary disease and / or hypoxemia
|Pulmonary hypertension in pulmonary disease and / or hypoxemia
 
|
*Chronic obstructive pulmonary disease(COPD)
*Chronic obstructive pulmonary disease(COPD)
*Interstitial lung disease
*Interstitial lung disease
Line 32: Line 31:


*Congenital malformations / developmental
*Congenital malformations / developmental
Pulmonary hypertension due to chronic thrombotic and / or embolic processes
|-
 
|Pulmonary hypertension due to chronic thrombotic and / or embolic processes
|-
|
*Thromboembolic obstruction of proximal pulmonary arteries
*Thromboembolic obstruction of proximal pulmonary arteries
*Thromboembolic obstruction of distal pulmonary arteries
*Thromboembolic obstruction of distal pulmonary arteries
*embolism of the lung(eg tumor, parasites, foreign body, bone marrow)
*embolism of the lung(eg tumor, parasites, foreign body, bone marrow)
 
|-
Pulmonary hypertension as a result of other diseases and disorders
|Pulmonary hypertension as a result of other diseases and disorders
 
|
*Sarcoidosis
*Sarcoidosis
*Histiocytosis X
*Histiocytosis X
Line 49: Line 50:
|}
|}
 
 
Evidence of pulmonary hypertension
==Evidence of pulmonary hypertension==
 Unlikely Possible Likely
 
SPAP <36 mmHg 36-50 mmHg > 50 mmHg
{| class="wikitable" cellpadding="0" cellspacing="0" border="0" width="800px"
TR Vmax < 2.8 m / s 2.9-3.4 m / s > 3.4 m / s
|-
Acct > 120 ms 120-60 ms <60 ms
!
RV MPI(TCO-ET/ET) < 0.36
!Unlikely
RV MPI(TDI) < 0:50
!Possible  
!Likely
|-
|SPAP  
|<36 mmHg  
|36-50 mmHg  
|>50 mmHg
|-
|TR Vmax  
|<2.8 m/s  
|2.9-3.4 m/s  
|>3.4 m/s
|-
|AccT
|>120 ms  
|120-60 ms  
|<60 ms
|-
|RV MPI (TCO-ET/ET)  
|<0.36
|
|
|-
|RV MPI (TDI)  
|<0:50
|
|
|}
 
==Calculations for estimating pressure in the pulmonary artery==
 
 
Calculations for estimating pressure in the pulmonary artery
{| class="wikitable" cellpadding="0" cellspacing="0" border="0" width="800px"
 formula
|-
Systolic PA pressure 4 x(TR Vmax) ² + estimated RA pressure
!
!Formula
|-
|Systolic PA pressure 4 x(TR Vmax) ² + estimated RA pressure
Diastolic PA pressure 4 x(PR Ved) ² + estimated RA pressure
Diastolic PA pressure 4 x(PR Ved) ² + estimated RA pressure
Mean PA pressure 0.3 x systolic PA pressure + 0.6 x diastolic PA pressure
Mean PA pressure 0.3 x systolic PA pressure + 0.6 x diastolic PA pressure
Line 65: Line 98:
4 x(PR Vmax) ² + estimated RA pressure
4 x(PR Vmax) ² + estimated RA pressure
TR PGmean + estimated RA pressure
TR PGmean + estimated RA pressure
 
|}
 
Example severe pulmonary hypertension
Example severe pulmonary hypertension



Revision as of 16:55, 25 January 2014

Pulmonary hypertension is a rare cause of high blood pressure(hypertension) in the pulmonary artery(pulmonary artery). When the blood vessels of the lungs becomes damaged, such as in pulmonary arterial hypertension, the thickening and stiffening of the pulmonary artery walls occur which causes deviations in the vessel wall. The consequence of this is that the pressure in the pulmonary artery rises and also in the RV. PH is a pressure load on the right heart. Click here to see an animation about PH.

WHO classification

Pulmonary hypertension is classified by the World Health Organization (WHO) as the place where the obstruction lies.

Classification Subcategories
Pulmonary Arterial Hypertension(PAH)
  • Idiopathic PAH(unknown cause)
  • Familial PAH(genetic cause)
  • PAH by underlying causes as, connective tissue diseases, congenital heart disease, portal hypertension, HIV infection, drugs, drugs, toxins, and other factors.
  • PAH with significant venous and / or capillary involvement
  • Persistent pulmonary hypertension of newborn
Pulmonary hypertension with left heart disease
  • In disorders of left atrium and ventricle

of the heart

  • With Valvular
Pulmonary hypertension in pulmonary disease and / or hypoxemia
  • Chronic obstructive pulmonary disease(COPD)
  • Interstitial lung disease
  • Sleep disorders, alveolar hypoventilation ;

chronic exposure to high altitude

  • Congenital malformations / developmental
Pulmonary hypertension due to chronic thrombotic and / or embolic processes
  • Thromboembolic obstruction of proximal pulmonary arteries
  • Thromboembolic obstruction of distal pulmonary arteries
  • embolism of the lung(eg tumor, parasites, foreign body, bone marrow)
Pulmonary hypertension as a result of other diseases and disorders
  • Sarcoidosis
  • Histiocytosis X
  • Lymfangioleiomyomatose
  • Sickle Cells
  • Compression of the pulmonary vessels from outside(eg by lymphadenopathy, tumor, fibrosing mediastinitis)
  • storage disorders

 

Evidence of pulmonary hypertension

Unlikely Possible Likely
SPAP <36 mmHg 36-50 mmHg >50 mmHg
TR Vmax <2.8 m/s 2.9-3.4 m/s >3.4 m/s
AccT >120 ms 120-60 ms <60 ms
RV MPI (TCO-ET/ET) <0.36
RV MPI (TDI) <0:50

Calculations for estimating pressure in the pulmonary artery

 

Formula
Systolic PA pressure 4 x(TR Vmax) ² + estimated RA pressure

Diastolic PA pressure 4 x(PR Ved) ² + estimated RA pressure Mean PA pressure 0.3 x systolic PA pressure + 0.6 x diastolic PA pressure 90 - (0.62 x ACCT) if Acct < 120ms 4 x(PR Vmax) ² + estimated RA pressure TR PGmean + estimated RA pressure

Example severe pulmonary hypertension

Short acct with "systolic notch" Flattened septum

Increased Systolic PA pressure Increased MPI, extension of isovolumetric times. Source : Eur Respir Rev 2012 ; 21: 125, 239-248

References

  1. Habib G, Badano L, Tribouilloy C, Vilacosta I, Zamorano JL, Galderisi M, Voigt JU, Sicari R, Cosyns B, Fox K, Aakhus S, and European Association of Echocardiography. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr. 2010 Mar;11(2):202-19. DOI:10.1093/ejechocard/jeq004 | PubMed ID:20223755 | HubMed [1]